Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HTR4 | Q13639 | 3/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL664690 | 0.84 | CA12 (0.53) | MEN1KMT2AKDM4EALDH1A1TSHR | |
| SCHEMBL2733785 | 0.82 | ALDH1A1 (0.43) | HSD17B10MEN1KMT2AKDM4EGAA | |
| SCHEMBL4420717 | 0.82 | CA12 (0.54) | MEN1KMT2AKDM4EALDH1A1TSHR | |
| SCHEMBL10802653 | 0.81 | MEN1 (0.42) | HSD17B10MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL28434860 | 0.81 | ALDH1A1 (0.48) | HSD17B10MEN1KMT2AKDM4EGAA | |
| SCHEMBL22343645 | 0.81 | HDAC2 (0.49) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL10359623 | 0.80 | HSD17B10 (0.59) | HSD17B10MEN1KMT2AKDM4EGAA | |
| SCHEMBL15032035 | 0.80 | ALDH1A1 (0.47) | HSD17B10MEN1KMT2AKDM4EGAA | |
| SCHEMBL3366797 | 0.79 | MAPK1 (0.41) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL793119 | 0.79 | MEN1 (0.57) | MEN1KMT2AKDM4EALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3063210-A2 | METHOD OF THIOPHENOL REMOVAL FROM POLY(ARYLENE SULFIDE) POLYMER COMPOSITIONS | SOLVAY SA (BE) | 2016-09-07 | — | — | EP | disclosed |
| US-9388282-B2 | Method of thiophenol removal from poly(arylene sulfide) polymer compositions | SOLVAY SPECIALTY POLYMERS USA, LLC. (US) | 2016-07-12 | — | — | US | disclosed |
| WO-2015065906-A2 | METHOD OF THIOPHENOL REMOVAL FROM POLY(ARYLENE SULFIDE) POLYMER COMPOSITIONS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-05-07 | — | — | WO | disclosed |
| US-20150119550-A1 | Method of Thiophenol Removal from Poly(Arylene Sulfide) Polymer Compositions | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-04-30 | — | — | US | disclosed |
| US-8889802-B2 | Polymer compositions and methods of making and using same | POLYMERIGHT, INC. (US) | 2014-11-18 | — | — | US | disclosed |
| EP-2563368-A1 | PIPERAZINOTRIAZINES AS PI3K INHIBITORS FOR USE IN THE TREATMENT ANTIPROLIFERATIVE DISORDERS | University of Basel (CH) | 2013-03-06 | — | — | EP | disclosed |
| US-20130040912-A1 | PIPERAZINOTRIAZINES AS PI3K INHIBITORS FOR USE IN THE TREATMENT ANTIPROLIFERATIVE DISORDERS | UNIVERSITY OF BASEL (CH) | 2013-02-14 | — | — | US | disclosed |
| US-20120130040-A1 | Polymer Compositions and Methods of Making and Using Same | POLYMERIGHT, INC. (US) | 2012-05-24 | — | — | US | disclosed |
| EP-2448990-A1 | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Polymeright Inc. (US) | 2012-05-09 | — | — | EP | disclosed |
| US-8138278-B2 | Polymer compositions and methods of making and using same | POLYMERIGHT, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| WO-2011135520-A1 | PIPERAZINOTRIAZINES AS PI3K INHIBITORS FOR USE IN THE TREATMENT ANTIPROLIFERATIVE DISORDERS | UNIVERSITY OF BASEL (CH) | 2011-11-03 | — | — | WO | disclosed |
| US-20110152492-A1 | Polymer Compositions and Methods of Making and Using Same | POLYMERIGHT, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2011008480-A1 | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME | POLYMERIGHT, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
| US-7585932-B2 | Polymer compositions and processes for making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-09-08 | — | — | US | disclosed |
| EP-1940917-A2 | POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070055033-A1 | POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-03-08 | — | — | US | disclosed |
| WO-2007021960-A2 | POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
| US-5422121-A | Oral dosage unit form | ROHM GMBH (DE) | 1995-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040912-A1 | PIPERAZINOTRIAZINES AS PI3K INHIBITORS FOR USE IN THE TREATMENT ANTIPROLIFERATIVE DISORDERS | CDK4, MTOR, RPTOR | HSD17B10 3088/4885MEN1 1744/4885KMT2A 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.